Faes Farma Stock | FAE.MC | ES0134950F36 | A0MKAC

Date	Faes Farma Price
2/24/2025	0 undefined
2/21/2025	3.73 undefined
2/20/2025	3.69 undefined
2/19/2025	3.67 undefined
2/18/2025	3.69 undefined
2/17/2025	3.68 undefined
2/14/2025	3.66 undefined
2/13/2025	3.63 undefined
2/12/2025	3.62 undefined
2/11/2025	3.63 undefined
2/10/2025	3.66 undefined
2/7/2025	3.66 undefined
2/6/2025	3.65 undefined
2/5/2025	3.57 undefined
2/4/2025	3.56 undefined
2/3/2025	3.53 undefined
1/31/2025	3.54 undefined
1/30/2025	3.54 undefined
1/29/2025	3.55 undefined
1/28/2025	3.54 undefined
1/27/2025	3.49 undefined

Date	Faes Farma Revenue	Faes Farma EBIT	Faes Farma Net Income
2027e	521.46 M undefined	106.2 M undefined	91.89 M undefined
2026e	523.67 M undefined	114.17 M undefined	96.88 M undefined
2025e	513.27 M undefined	111.29 M undefined	96.61 M undefined
2024e	500.74 M undefined	107.26 M undefined	93.42 M undefined
2023	451.17 M undefined	102.84 M undefined	91.9 M undefined
2022	438.75 M undefined	101.92 M undefined	89.55 M undefined
2021	398.56 M undefined	97.11 M undefined	82.39 M undefined
2020	380.24 M undefined	92.31 M undefined	72.55 M undefined
2019	357.4 M undefined	78.98 M undefined	63.96 M undefined
2018	324.31 M undefined	62.01 M undefined	51.59 M undefined
2017	274.58 M undefined	49.07 M undefined	41.38 M undefined
2016	228.64 M undefined	48.04 M undefined	36.59 M undefined
2015	204.72 M undefined	41.52 M undefined	30.36 M undefined
2014	191.7 M undefined	36.2 M undefined	25.3 M undefined
2013	180.4 M undefined	28.6 M undefined	22.6 M undefined
2012	176.1 M undefined	22.8 M undefined	19.5 M undefined
2011	195.7 M undefined	16.3 M undefined	14.2 M undefined
2010	211.4 M undefined	24.7 M undefined	20 M undefined
2009	199.4 M undefined	25.4 M undefined	21.3 M undefined
2008	196.9 M undefined	26 M undefined	19.6 M undefined
2007	203.9 M undefined	21.4 M undefined	21.9 M undefined
2006	192.5 M undefined	23.3 M undefined	22.8 M undefined
2005	168.7 M undefined	19.9 M undefined	23.3 M undefined
2004	165.1 M undefined	15.1 M undefined	20.6 M undefined

	Revenue	EBIT	Net Income
2004	165.1 M EUR	15.1 M EUR	20.6 M EUR
2005	168.7 M EUR	19.9 M EUR	23.3 M EUR
2006	192.5 M EUR	23.3 M EUR	22.8 M EUR
2007	203.9 M EUR	21.4 M EUR	21.9 M EUR
2008	196.9 M EUR	26 M EUR	19.6 M EUR
2009	199.4 M EUR	25.4 M EUR	21.3 M EUR
2010	211.4 M EUR	24.7 M EUR	20 M EUR
2011	195.7 M EUR	16.3 M EUR	14.2 M EUR
2012	176.1 M EUR	22.8 M EUR	19.5 M EUR
2013	180.4 M EUR	28.6 M EUR	22.6 M EUR
2014	191.7 M EUR	36.2 M EUR	25.3 M EUR
2015	204.72 M EUR	41.52 M EUR	30.36 M EUR
2016	228.64 M EUR	48.04 M EUR	36.59 M EUR
2017	274.58 M EUR	49.07 M EUR	41.38 M EUR
2018	324.31 M EUR	62.01 M EUR	51.59 M EUR
2019	357.4 M EUR	78.98 M EUR	63.96 M EUR
2020	380.24 M EUR	92.31 M EUR	72.55 M EUR
2021	398.56 M EUR	97.11 M EUR	82.39 M EUR
2022	438.75 M EUR	101.92 M EUR	89.55 M EUR
2023	451.17 M EUR	102.84 M EUR	91.9 M EUR
2024e	500.74 M EUR	107.26 M EUR	93.42 M EUR
2025e	513.27 M EUR	111.29 M EUR	96.61 M EUR
2026e	523.67 M EUR	114.17 M EUR	96.88 M EUR
2027e	521.46 M EUR	106.2 M EUR	91.89 M EUR

2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
22	20	21	18	19	21	20	14	19	22	25	30	36	41	51	64	73	83	89	91
13	14	15	14	8	8	9	9	8	7	6	5	5	8	10	12	14	16	19	19
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	3	0
-10	-22	-21	-14	0	-12	-20	-6	-7	-5	-11	-8	-9	-18	-16	-30	-35	-36	-18	-25
-6	1	4	-6	5	4	6	3	3	7	11	13	17	9	13	21	25	16	16	14
2	1	2	3	5	2	2	2	2	1	0	0	0	0	0	0	0	0	0	0
6	5	3	3	5	4	3	1	2	4	3	2	3	4	4	5	5	9	7	8
18	13	19	13	34	22	15	19	23	31	32	40	49	41	59	67	78	79	106	100
-9	-28	-15	-14	-16	-11	-10	-8	-2	-4	-4	-10	-11	-16	-19	-21	-25	-59	-80	-102
-6	-24	-14	-23	-11	-13	-9	-1	-1	-4	-3	-10	-11	-83	-19	-34	-25	-83	-92	-97
3	4	0	-8	5	-2	1	6	1	0	0	0	0	-66	0	-12	0	-24	-11	4
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-2	14	3	24	-4	13	4	-3	-18	-23	-26	-7	0	31	-1	-43	-2	-1	0	0
10	0	0	0	0	0	0	0	0	0	-1	0	0	0	-1	-2	0	0	0	-17
-6	4	-9	14	-21	-6	-13	-14	-23	-23	-30	-11	-4	25	-7	-56	-14	-17	-18	-35
-2	2	1	0	-2	-4	0	-3	0	0	-1	0	0	0	3	0	0	-1	0	-3
-11	-12	-14	-10	-13	-15	-16	-7	-6	0	0	-4	-5	-6	-7	-10	-12	-13	-18	-14
6	-6	-4	3	2	1	-7	3	-1	3	-1	18	33	-15	32	-23	38	-20	-3	-31
8.78	-15.25	4.81	-1.79	18.09	11.4	5.17	11.92	21.12	27.48	28.11	30.77	37.64	25.08	39.82	46.18	52.77	20.23	25.84	-1.22
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Faes Farma Gross margin	Faes Farma Profit margin	Faes Farma EBIT margin	Faes Farma Profit margin
2027e	65.86 %	20.37 %	17.62 %
2026e	65.86 %	21.8 %	18.5 %
2025e	65.86 %	21.68 %	18.82 %
2024e	65.86 %	21.42 %	18.66 %
2023	65.86 %	22.79 %	20.37 %
2022	64.28 %	23.23 %	20.41 %
2021	63.33 %	24.37 %	20.67 %
2020	63.08 %	24.28 %	19.08 %
2019	63.63 %	22.1 %	17.9 %
2018	62.94 %	19.12 %	15.91 %
2017	64.88 %	17.87 %	15.07 %
2016	66.13 %	21.01 %	16 %
2015	65.34 %	20.28 %	14.83 %
2014	65.73 %	18.88 %	13.2 %
2013	63.53 %	15.85 %	12.53 %
2012	64.22 %	12.95 %	11.07 %
2011	62.03 %	8.33 %	7.26 %
2010	60.26 %	11.68 %	9.46 %
2009	60.88 %	12.74 %	10.68 %
2008	60.84 %	13.2 %	9.95 %
2007	66.36 %	10.5 %	10.74 %
2006	66.65 %	12.1 %	11.84 %
2005	67.1 %	11.8 %	13.81 %
2004	66.51 %	9.15 %	12.48 %

	Gross margin	EBIT margin	Profit margin
2004	66.51 %	9.15 %	12.48 %
2005	67.1 %	11.8 %	13.81 %
2006	66.65 %	12.1 %	11.84 %
2007	66.36 %	10.5 %	10.74 %
2008	60.84 %	13.2 %	9.95 %
2009	60.88 %	12.74 %	10.68 %
2010	60.26 %	11.68 %	9.46 %
2011	62.03 %	8.33 %	7.26 %
2012	64.22 %	12.95 %	11.07 %
2013	63.53 %	15.85 %	12.53 %
2014	65.73 %	18.88 %	13.2 %
2015	65.34 %	20.28 %	14.83 %
2016	66.13 %	21.01 %	16 %
2017	64.88 %	17.87 %	15.07 %
2018	62.94 %	19.12 %	15.91 %
2019	63.63 %	22.1 %	17.9 %
2020	63.08 %	24.28 %	19.08 %
2021	63.33 %	24.37 %	20.67 %
2022	64.28 %	23.23 %	20.41 %
2023	65.86 %	22.79 %	20.37 %
2024e	65.86 %	21.42 %	18.66 %
2025e	65.86 %	21.68 %	18.82 %
2026e	65.86 %	21.8 %	18.5 %
2027e	65.86 %	20.37 %	17.62 %

Date	Faes Farma Sales per Share	Faes Farma EBIT per share	Faes Farma Earnings per Share
2027e	1.65 undefined	0 undefined	0.29 undefined
2026e	1.66 undefined	0 undefined	0.31 undefined
2025e	1.62 undefined	0 undefined	0.31 undefined
2024e	1.58 undefined	0 undefined	0.3 undefined
2023	1.45 undefined	0.33 undefined	0.3 undefined
2022	1.39 undefined	0.32 undefined	0.28 undefined
2021	1.21 undefined	0.29 undefined	0.25 undefined
2020	1.2 undefined	0.29 undefined	0.23 undefined
2019	1.17 undefined	0.26 undefined	0.21 undefined
2018	1.06 undefined	0.2 undefined	0.17 undefined
2017	0.93 undefined	0.17 undefined	0.14 undefined
2016	0.76 undefined	0.16 undefined	0.12 undefined
2015	0.7 undefined	0.14 undefined	0.1 undefined
2014	0.7 undefined	0.13 undefined	0.09 undefined
2013	0.65 undefined	0.1 undefined	0.08 undefined
2012	0.64 undefined	0.08 undefined	0.07 undefined
2011	0.69 undefined	0.06 undefined	0.05 undefined
2010	0.74 undefined	0.09 undefined	0.07 undefined
2009	0.7 undefined	0.09 undefined	0.07 undefined
2008	0.75 undefined	0.1 undefined	0.07 undefined
2007	0.87 undefined	0.09 undefined	0.09 undefined
2006	0.82 undefined	0.1 undefined	0.1 undefined
2005	0.73 undefined	0.09 undefined	0.1 undefined
2004	0.71 undefined	0.07 undefined	0.09 undefined

	Sales per Share	EBIT per share	Earnings per Share
2004	0.71 EUR	0.07 EUR	0.09 EUR
2005	0.73 EUR	0.09 EUR	0.1 EUR
2006	0.82 EUR	0.1 EUR	0.1 EUR
2007	0.87 EUR	0.09 EUR	0.09 EUR
2008	0.75 EUR	0.1 EUR	0.07 EUR
2009	0.7 EUR	0.09 EUR	0.07 EUR
2010	0.74 EUR	0.09 EUR	0.07 EUR
2011	0.69 EUR	0.06 EUR	0.05 EUR
2012	0.64 EUR	0.08 EUR	0.07 EUR
2013	0.65 EUR	0.1 EUR	0.08 EUR
2014	0.7 EUR	0.13 EUR	0.09 EUR
2015	0.7 EUR	0.14 EUR	0.1 EUR
2016	0.76 EUR	0.16 EUR	0.12 EUR
2017	0.93 EUR	0.17 EUR	0.14 EUR
2018	1.06 EUR	0.2 EUR	0.17 EUR
2019	1.17 EUR	0.26 EUR	0.21 EUR
2020	1.2 EUR	0.29 EUR	0.23 EUR
2021	1.21 EUR	0.29 EUR	0.25 EUR
2022	1.39 EUR	0.32 EUR	0.28 EUR
2023	1.45 EUR	0.33 EUR	0.3 EUR
2024e	1.58 EUR	0 EUR	0.3 EUR
2025e	1.62 EUR	0 EUR	0.31 EUR
2026e	1.66 EUR	0 EUR	0.31 EUR
2027e	1.65 EUR	0 EUR	0.29 EUR

	Number of stocks
2004	232.2 M Aktien
2005	232.2 M Aktien
2006	234.6 M Aktien
2007	234.6 M Aktien
2008	263.9 M Aktien
2009	285.8 M Aktien
2010	285.6 M Aktien
2011	282.8 M Aktien
2012	276.6 M Aktien
2013	278.1 M Aktien
2014	272.5 M Aktien
2015	293.53 M Aktien
2016	298.94 M Aktien
2017	295.71 M Aktien
2018	306.07 M Aktien
2019	306.08 M Aktien
2020	316.33 M Aktien
2021	329.67 M Aktien
2022	316.63 M Aktien
2023	310.73 M Aktien
2024e	310.73 M Aktien
2025e	310.73 M Aktien
2026e	310.73 M Aktien
2027e	310.73 M Aktien

Date	Faes Farma Dividend
2027e	0.17 undefined
2026e	0.17 undefined
2025e	0.17 undefined
2024e	0.17 undefined
2023	0.16 undefined
2022	0.04 undefined
2021	0.2 undefined
2020	0.19 undefined
2019	0.16 undefined
2018	0.13 undefined
2017	0.11 undefined
2016	0.09 undefined
2015	0.08 undefined
2014	0.08 undefined
2013	0.05 undefined
2012	0.04 undefined
2011	0.03 undefined
2010	0.06 undefined
2009	0.05 undefined
2008	0.05 undefined
2007	0.04 undefined
2006	0.05 undefined
2005	0.04 undefined
2004	0.04 undefined

	Dividend	Dividend (Estimate)
2004	0.04 EUR	0 EUR
2005	0.04 EUR	0 EUR
2006	0.05 EUR	0 EUR
2007	0.04 EUR	0 EUR
2008	0.05 EUR	0 EUR
2009	0.05 EUR	0 EUR
2010	0.06 EUR	0 EUR
2011	0.03 EUR	0 EUR
2012	0.04 EUR	0 EUR
2013	0.05 EUR	0 EUR
2014	0.08 EUR	0 EUR
2015	0.08 EUR	0 EUR
2016	0.09 EUR	0 EUR
2017	0.11 EUR	0 EUR
2018	0.13 EUR	0 EUR
2019	0.16 EUR	0 EUR
2020	0.19 EUR	0 EUR
2021	0.2 EUR	0 EUR
2022	0.04 EUR	0 EUR
2023	0.16 EUR	0 EUR
2024e	0 EUR	0.17 EUR
2025e	0 EUR	0.17 EUR
2026e	0 EUR	0.17 EUR
2027e	0 EUR	0.17 EUR

Date	Faes Farma Payout ratio
2027e	46.86 %
2026e	49.81 %
2025e	40.45 %
2024e	50.32 %
2023	58.66 %
2022	12.38 %
2021	79.91 %
2020	83.69 %
2019	75.02 %
2018	76.24 %
2017	76.22 %
2016	76.22 %
2015	74.24 %
2014	85.36 %
2013	60.56 %
2012	59.6 %
2011	53.1 %
2010	81.4 %
2009	73.96 %
2008	65.74 %
2007	40.73 %
2006	49.35 %
2005	43.86 %
2004	43.47 %

	Payout ratio
2004	43.47 %
2005	43.86 %
2006	49.35 %
2007	40.73 %
2008	65.74 %
2009	73.96 %
2010	81.4 %
2011	53.1 %
2012	59.6 %
2013	60.56 %
2014	85.36 %
2015	74.24 %
2016	76.22 %
2017	76.22 %
2018	76.24 %
2019	75.02 %
2020	83.69 %
2021	79.91 %
2022	12.38 %
2023	58.66 %
2024e	50.32 %
2025e	40.45 %
2026e	49.81 %
2027e	46.86 %

Date	EPS Estimate	EPS Actual	Quarterly report
9/30/2012	0.04	0.03 (-17.61 %)	2012 Q3
12/31/2011	0	0 (0 %)	2011 Q4
12/31/2010	0.03	0 (-100 %)	2010 Q4
6/30/2010	0.02	0.01 (-20.9 %)	2010 Q2
12/31/2009	0.01	0.01 (-45.43 %)	2009 Q4
12/31/2007	0	0.01 (78.04 %)	2007 Q4
12/31/2006	0.04	0.01 (-72.25 %)	2006 Q4

%	Name	Stocks	Change	Date
5.33007 %	Indumenta Pueri, S.L.	16,854,736	0	4/18/2024
5.01152 %	Alantra Asset Management SGIIC, S.A.	15,847,420	19,259	9/5/2024
2.88840 %	The Vanguard Group, Inc.	9,133,697	-29,740	9/30/2024
1.52404 %	BlackRock Institutional Trust Company, N.A.	4,819,317	20,571	9/30/2024
1.29556 %	Dimensional Fund Advisors, L.P.	4,096,805	0	8/31/2024
1.28248 %	Fidelity Management & Research Company LLC	4,055,449	0	8/31/2024
0.91590 %	Norges Bank Investment Management (NBIM)	2,896,272	-1,668,146	6/30/2024
0.79001 %	Zavala Ortiz de la Torre (Iñigo)	2,498,169	105,141	12/31/2023
0.66386 %	Santander Asset Management	2,099,272	0	6/30/2024
0.66136 %	Argenta Asset Management SA	2,091,352	0	6/30/2023
0.51419 %	Fidelity Institutional Asset Management	1,625,960	1,208,107	8/31/2024
0.51001 %	Ucar Angulo (Mariano)	1,612,742	68,750	12/31/2023
0.34000 %	Alcocer Torra (Carlos)	1,075,161	49,578	12/31/2023
0.32000 %	Fernandez de Valderrama Iribarnegaray (Gonzalo)	1,011,917	17,412	12/31/2023
0.31155 %	Charles Schwab Investment Management, Inc.	985,183	-5,300	8/31/2024
0.30495 %	Praude Asset Management Ltd.	964,321	0	6/30/2024
0.25951 %	BlackRock Advisors (UK) Limited	820,622	2,272	9/30/2024
0.25444 %	Mellon Investments Corporation	804,579	-10,486	8/31/2024
0.22254 %	DWS Investment GmbH	703,731	21,413	9/30/2024
0.20307 %	Caixabank Asset Management SGIIC, S.A.U.	642,146	0	6/30/2024
0.20270 %	State Street Global Advisors (US)	640,987	-3,121	9/30/2024
0.18570 %	Dimensional Fund Advisors, Ltd.	587,234	0	9/30/2024
0.18337 %	AllianceBernstein L.P.	579,848	0	8/31/2024
0.17922 %	Magallanes Value Investors, S.A., SGIIC	566,722	0	6/30/2024
0.17782 %	Nuveen LLC	562,314	0	7/31/2024
0.15829 %	Robeco Institutional Asset Management B.V.	500,542	0	8/31/2024
0.14464 %	Bessemer Trust Company, N.A. (US)	457,390	0	7/31/2024
0.12221 %	Andbank Wealth Management, SGIIC, S.A.U.	386,467	-12,413	9/30/2024
0.11850 %	Amundi Asset Management, SAS	374,735	52,681	9/30/2024
0.11693 %	Teachers Advisors, LLC	369,759	0	7/31/2024
0.10583 %	California State Teachers Retirement System	334,649	73,390	6/30/2023
0.08059 %	Geode Capital Management, L.L.C.	254,844	-3,848	8/31/2024
0.06441 %	UBS Asset Management (Switzerland)	203,674	0	9/30/2024
0.05258 %	BlackRock Asset Management Canada Limited	166,280	0	9/30/2024
0.04717 %	Franklin Templeton Portfolio Advisors, Inc	149,150	-1,550	9/30/2024
0.04455 %	Parametric Portfolio Associates LLC	140,872	0	6/30/2024
0.04376 %	Renta 4 Gestora, S.G.I.I.C., S.A.	138,378	-46,536	6/30/2024
0.03893 %	Roche Brune SAS	123,098	45,988	12/31/2023
0.03893 %	APICIL Asset Management SA	123,098	34,518	6/30/2024
0.03778 %	UBS Asset Management (UK) Ltd.	119,474	0	8/31/2024
0.03188 %	BG Fund Management Luxembourg S.A.	100,825	-21,615	7/31/2024
0.03143 %	State Street Global Advisors Ireland Limited	99,397	6,921	9/30/2024
0.03124 %	Northern Trust Global Investments Limited	98,783	0	8/31/2024
0.02809 %	Mercer Global Investments Management Ltd	88,830	0	4/30/2024
0.02688 %	Caja Ingenieros Gesti¿n, SGIIC, SAU	85,000	5,000	6/30/2024
0.02627 %	HWB Capital Management S.A.	83,075	0	1/31/2024
0.02587 %	DFA Australia Ltd.	81,797	-8	7/31/2024
0.02447 %	Quoniam Asset Management GmbH	77,372	0	6/30/2024
0.02202 %	Z¿rcher Kantonalbank (Asset Management)	69,628	0	7/31/2024
0.02200 %	KLP Fondsforvaltning AS	69,567	15,499	9/30/2024
0.02182 %	Mediolanum International Funds Limited	69,013	0	3/31/2024
0.02159 %	Vanguard Investments Australia Ltd.	68,276	47	8/31/2024
0.02131 %	Florida State Board of Administration	67,380	323	6/30/2024
0.02050 %	BlackRock Investment Management (UK) Ltd.	64,815	0	6/30/2024
0.01965 %	Mackenzie Investments	62,145	35,374	6/30/2024
0.01834 %	Caja Laboral Gestión S.G.I.I.C., S.A.	58,010	0	6/30/2024
0.01783 %	Irish Life Investment Managers Ltd.	56,387	-1,616	9/30/2024
0.01651 %	American Century Investment Management, Inc.	52,207	0	6/30/2024
0.01546 %	Bankinter Gesti¿n de Activos, SGIIC S.A.	48,886	-223,456	6/30/2024
0.01477 %	HAC VermögensManagement AG	46,706	46,706	9/30/2024
0.01439 %	Finlabo SIM S.p. A.	45,500	9,500	9/30/2024
0.01224 %	Mayr Investment Managers GmbH	38,700	500	7/31/2024
0.01202 %	Inversis Gesti¿n, S.A., SGIIC	38,004	0	6/30/2024
0.01069 %	Gescooperativo, S.A., S.G.I.I.C.	33,807	0	6/30/2024
0.01001 %	Evli Fund Management Company Ltd.	31,664	0	9/30/2024
0.01000 %	Basagoiti Pastor (Carmen)	31,622	544	12/31/2023
0.00949 %	GVC Gaesco Gesti¿n SGIIC S.A.	30,000	-30,120	6/30/2024
0.00893 %	Legal & General Investment Management Ltd.	28,241	0	8/31/2024
0.00872 %	Acadian Asset Management LLC	27,579	0	9/30/2024
0.00836 %	Barclays Wealth Managers Espa¿a, S.A., S.G.I.I.C.	26,434	0	8/31/2023
0.00797 %	Gesiuris Asset Management S.G.I.I.C., S.A.	25,193	0	6/30/2024
0.00791 %	Hussman Strategic Advisors, Inc.	25,000	0	3/31/2023
0.00759 %	Danske Bank Asset Management	23,989	-21,147	8/31/2024
0.00632 %	DUX Inversores, SGIIC, S.A.	20,000	20,000	6/30/2024
0.00574 %	UBS Fund Management (Switzerland) AG	18,154	0	9/30/2024
0.00572 %	RAM Active Investments S.A.	18,094	-20,740	6/30/2024
0.00566 %	Northern Trust Investments, Inc.	17,897	0	9/30/2024
0.00550 %	SEI Investments Management Corporation	17,406	-14,989	4/30/2024
0.00529 %	DWS Investments UK Limited	16,732	-3,127	7/31/2024
0.00505 %	Pictet Asset Management Ltd.	15,969	0	6/30/2024
0.00471 %	ANDBANK Asset Management Luxembourg SA	14,886	0	12/31/2023
0.00252 %	Vanguard Global Advisers LLC	7,976	0	9/30/2024
0.00244 %	State Street Global Advisors Ltd. (Canada)	7,729	-273	6/30/2024
0.00193 %	Hotchkis and Wiley Capital Management, LLC	6,100	0	8/31/2024
0.00081 %	Dimensional Fund Advisors Canada ULC	2,561	0	5/31/2024
0.00057 %	DBX Advisors LLC.	1,817	0	8/31/2024
0.00022 %	Segall Bryant & Hamill, LLC	704	704	7/31/2024
0.00010 %	Welcome Asset Management SGIIC SA	327	0	8/31/2023
0.00010 %	Grantham Mayo Van Otterloo & Co LLC	307	0	3/31/2024
0 %	Fidelity Investments Canada ULC	0	-13,288	6/30/2023
0 %	Serafin Asset Management AG	0	-1,666,343	7/31/2023
0 %	Attitude Gesti¿n, S.G.I.I.C. S.A.	0	-300,000	6/30/2024
0 %	Trea Asset Management S.G.I.I.C., S.A.	0	-115,938	12/31/2023
0 %	PSM Verm¿gensverwaltung GmbH	0	-49,473	1/31/2023
0 %	Value Square N.V.	0	-63,751	2/29/2024
0 %	Degroof Petercam Asset Management	0	-1,832	7/31/2023
0 %	Invesco Capital Management LLC	0	-43,326	3/31/2024
0 %	Consultinvest Asset Management SGR S.p.A.	0	-20,000	3/31/2023
0 %	Unigest, S.G.I.I.C., S.A.	0	-50,631	3/31/2023
0 %	Credit Agricole Mercagestion S.A. S.G.I.I.C.	0	-42,034	6/30/2023

What values and corporate philosophy does Faes Farma represent?

Faes Farma SA represents values and a corporate philosophy centered on innovation, excellence, and commitment to improving healthcare. With a focus on research and development, the company strives to develop high-quality pharmaceutical products that address unmet medical needs. With a long history dating back to 1933, Faes Farma SA emphasizes ethical business practices and sustainable growth. By leveraging its scientific expertise and state-of-the-art technologies, the company aims to provide effective therapies and contribute to the well-being of patients worldwide. Faes Farma SA's dedication to innovation and patient-centric approach makes it a reputable player in the pharmaceutical industry.

In which countries and regions is Faes Farma primarily present?

Faes Farma SA is primarily present in Spain and Portugal.

What significant milestones has the company Faes Farma achieved?

Faes Farma SA, a leading pharmaceutical company, has achieved several significant milestones throughout its history. One notable milestone is the successful development and commercialization of innovative pharmaceutical products. The company has also expanded its market reach globally, establishing a strong presence in various countries. Furthermore, Faes Farma SA has demonstrated continuous growth through strategic partnerships, collaborations, and acquisitions. These milestones reflect the company's commitment to advancing healthcare and delivering quality solutions to customers worldwide. With its relentless dedication and industry expertise, Faes Farma SA has emerged as a prominent player in the pharmaceutical sector, consistently achieving commendable results.

What is the history and background of the company Faes Farma?

Faes Farma SA is a leading pharmaceutical company with a rich history and strong background. Established in 1933, Faes Farma has grown steadily over the years to become a key player in the healthcare industry. The company specializes in the research, development, manufacturing, and commercialization of innovative drugs and health products. With a primary focus on respiratory, allergy, and anti-inflammatory treatments, Faes Farma has built a solid reputation for delivering high-quality and effective pharmaceutical solutions. Through continuous innovation and strategic partnerships, the company has successfully expanded its global presence and has become a trusted name in the pharmaceutical sector.

Who are the main competitors of Faes Farma in the market?

Some of the main competitors of Faes Farma SA in the market include pharmaceutical companies like Grupo Ferrer Internacional, Laboratorios Rubió, Almirall, and Laboratorios Normon.

In which industries is Faes Farma primarily active?

Faes Farma SA is primarily active in the pharmaceutical industry.

What is the business model of Faes Farma?

The business model of Faes Farma SA is focused on the research, development, manufacture, and commercialization of pharmaceutical products. The company specializes in the areas of prescription drugs, hospital medications, and non-prescription drugs. Faes Farma SA operates through a diversified portfolio, catering to various therapeutic areas such as respiratory, dermatology, allergy, and gastrointestinal disorders. The company aims to provide innovative and effective solutions to improve people's health and quality of life. Faes Farma SA's commitment to scientific excellence, strategic partnerships, and continuous product development enables it to meet the evolving needs of patients worldwide.

What is the P/E ratio of Faes Farma 2025?

The P/E ratio cannot be calculated for Faes Farma at the moment.

What is the P/S ratio of Faes Farma 2025?

The P/S cannot be calculated for Faes Farma currently.

What is the Quality Investing of Faes Farma?

The Quality Investing for Faes Farma is 7/10.

What is the revenue of Faes Farma 2025?

The expected Faes Farma revenue is 513.27 M EUR.

How high is the profit of Faes Farma 2025?

The expected Faes Farma profit is 96.61 M EUR.

What is the business model of Faes Farma

Faes Farma SA is a leading pharmaceutical company specializing in the manufacturing and marketing of medicines and medical products. The company was founded in 1933 and is headquartered in Barcelona, Spain. Faes Farma operates in various business areas, including pharmaceutical products, diagnostic and laboratory services, and skincare products. Pharmaceutical products Faes Farma offers a wide range of pharmaceutical products that can be used to treat various diseases and ailments. The company focuses on the development of drugs in the areas of pain medicine, allergology, and respiratory and eye diseases. One outstanding product is Bilastine, an antihistamine used to treat allergic diseases. In 2020, the company generated sales of €136 million with Bilastine. Diagnostic and laboratory services Faes Farma also operates a division for diagnostic and laboratory services. The company offers various tests to detect and treat diseases early. For example, Faes Farma offers a test to determine if a person is suffering from celiac disease. Another example is a test that detects the presence of antibodies against SARS-CoV-2. Skincare products The company also offers a line of skincare products marketed under the brand Bionike. These products have been specifically developed for people with sensitive skin and do not contain questionable ingredients. The product range includes face creams, cleansers, and sunscreens. Faes Farma has a diversified business model based on the development of new products and the expansion into new markets. The company is focused on innovation and invests a significant portion of its sales in research and development every year. Thanks to its innovative capacity and strong market presence, Faes Farma has experienced solid growth in recent years. In 2020, the company had sales of €317.2 million. The size of the company allows for international business expansion. Faes Farma operates in over 80 countries and has a strong presence, particularly in Latin America and Asia.

What is the Faes Farma dividend?

Faes Farma pays a dividend of 0.04 EUR distributed over 2 payouts per year.

How often does Faes Farma pay dividends?

Faes Farma pays out a dividend 2 times a year.

What is the Faes Farma ISIN?

The ISIN of Faes Farma is ES0134950F36.

What is the Faes Farma WKN?

The WKN of Faes Farma is A0MKAC.

What is the Faes Farma ticker?

The ticker of Faes Farma is FAE.MC.

How much dividend does Faes Farma pay?

Over the past 12 months, Faes Farma paid a dividend of 0.16 EUR . This corresponds to a dividend yield of about . For the coming 12 months, Faes Farma is expected to pay a dividend of 0.17 EUR.

What is the dividend yield of Faes Farma?

The current dividend yield of Faes Farma is .

When does Faes Farma pay dividends?

Faes Farma pays a quarterly dividend. This is distributed in the months of May, February, August, February.

How secure is the dividend of Faes Farma?

Faes Farma paid dividends every year for the past 24 years.

What is the dividend of Faes Farma?

For the upcoming 12 months, dividends amounting to 0.17 EUR are expected. This corresponds to a dividend yield of 4.47 %.

In which sector is Faes Farma located?

Faes Farma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Faes Farma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Faes Farma from 1/13/2025 amounting to 0.041 EUR, you needed to have the stock in your portfolio before the ex-date on 1/9/2025.

When did Faes Farma pay the last dividend?

The last dividend was paid out on 1/13/2025.

What was the dividend of Faes Farma in the year 2024?

In the year 2024, Faes Farma distributed 0.155 EUR as dividends.

In which currency does Faes Farma pay out the dividend?

The dividends of Faes Farma are distributed in EUR.

1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023

26.4	47.5	56.5	52.1	38.3	34.6	27.1	18.7	26.3	19.8	18.2	20.8	17	20.9	12.5	12.4	10.6	14.8	13.3	32.91	66.02	43.34	76.41	54.18	93.14	73.41	84.1	47.75
16.8	18.9	19.7	22.2	26.4	29.6	32.1	33.3	27.1	29	34.5	47.8	35.7	36.2	37.9	33.3	-0.7	37	38.1	43.04	45.6	72.16	77.06	90.48	98.77	101.49	101.17	113.51
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	5	42.2	1.9	4.1	3.22	3.47	4.09	4.48	6.34	6.13	11	12.43	0
13.4	13.6	13.2	15.9	20	21.9	23	21.2	23.5	23.9	25.5	28.4	27.5	29.5	36.2	32.5	30.5	31.1	32.9	34.03	38.29	49.87	59.31	71.45	91.59	107.45	115	129.03
-600	-1,100	-1,000	-1,200	-5,000	-4,400	-6,200	-400	0	0	0	0	0	400	300	400	400	300	300	272	285	372	330	539	375	360	518	573
56	78.9	88.4	89	79.7	81.7	76	72.8	76.9	72.7	78.2	97	80.2	87	87.7	83.6	83	85.1	88.7	113.47	153.66	169.83	217.58	222.99	290.01	293.71	313.21	290.86
12	13	13.7	15.4	17.5	18.2	20.7	23.9	24.9	26.8	28.6	31.1	33.3	33.3	32.1	29.2	25.7	23.1	22.5	30.43	38.41	60.56	67.06	83.93	95.25	139.63	205.8	280.62
18.8	7.5	4.9	5.1	2.3	2	0.3	0.3	1.8	2.2	2	1.8	1.8	1.8	1.7	1.7	1.7	1.7	1.6	1.58	1.72	1.92	1.88	2.01	1.89	2.54	6.68	1.89
0	0	0	0	0.9	1.9	7.5	9.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.42	0
13.9	13.4	11.7	21	38.6	36.7	65.9	85	69.9	91	88	91.4	95.6	97.7	97.5	112.7	91.4	87.8	81.5	76.19	72.8	111.33	111.74	106.99	112.88	129.43	126.91	184.75
3.1	2.2	1.9	1.6	0	0	0	0	0	0	6.7	17.3	17.3	17.3	17.3	0	17.3	17.3	17.3	17.35	17.35	53.19	53.94	61.5	52.64	53.33	51.78	56.08
3.4	0.3	3	3.9	6.5	7.2	6.5	6.5	17.4	23.4	29	37.9	46.8	55.8	60.8	64	67.8	58.9	55.6	51.66	47.29	32.67	19.01	16.25	28.85	26.47	21.29	19.04
51.2	36.4	35.2	47	65.8	66	100.9	125.2	114	143.4	154.3	179.5	194.8	205.9	209.4	207.6	203.9	188.8	178.5	177.21	177.57	259.67	253.62	270.68	291.51	351.4	424.88	542.37
107.2	115.3	123.6	136	145.5	147.7	176.9	198	190.9	216.1	232.5	276.5	275	292.9	297.1	291.2	286.9	273.9	267.2	290.68	331.22	429.5	471.2	493.67	581.52	645.11	738.09	833.23

11.9	9.3	4.1	6	6.6	7.3	8	8.9	9.9	11.1	12.6	14.2	16	18	19.5	20.5	20.5	22	23.5	24.79	25.5	26.16	27.01	27.82	28.52	29.74	31.08	31.62
4	2.8	0	0	0	0	0	0	0	0	1.5	1.5	1.5	1.5	1.5	1.5	1.5	1.5	1.5	1.46	1.46	1.46	1.46	1.46	1.46	1.46	1.46	1.46
64.6	79.1	94.6	94.5	95.2	93.5	98.5	107.1	110.1	120.4	127.4	136.8	141.1	145.2	146.6	148	165.2	176.7	207	231.28	261.27	295.69	336.69	388.96	449.16	512.93	579.09	643.38
800	700	700	700	700	700	700	700	0	100	-100	-300	-300	0	0	0	0	-100	0	7	-40	-57	-9	2	-2,489	-3,062	-5,285	-3,081
2.6	1.1	1.1	1.1	1.1	1.1	1.1	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
83.9	93	100.5	102.3	103.6	102.6	108.3	117.8	120	131.6	141.4	152.2	158.3	164.7	167.6	170	187.2	200.1	232	257.54	288.19	323.25	365.15	418.23	476.66	541.07	606.34	673.38
8.7	14.5	7.3	10.9	17.2	14.3	11.5	14.4	14.6	13	16.8	32	25.7	18.9	19.6	16	23.1	16.3	16.4	16.98	19.04	30.96	35.64	36.19	41.97	37.93	36.59	91.43
0.7	0.1	0.2	0.1	0.1	0	0.3	1.3	0	0	0	0	0	0	0	0	0	5.5	5.8	5.67	7.01	8.05	10.92	11.72	13.35	11.97	12	13.17
10.7	5.2	10.8	17.2	21.5	14	21.4	22.7	22	20.2	19.7	5.4	4.6	17.5	15.7	15.3	5.9	16.1	5.8	8.45	9.61	12.66	9.48	17.02	17.12	15.13	17.55	11.31
0	0	0	0	0	14	16.8	25.7	23.2	38.1	41.7	65.8	0.3	0.1	0.3	0.3	0	0	0	0	0	0	0	0	4.93	7.44	11.32	12.14
0	0	0	0	0	0	0	0	0	0	0	0	35.3	31	45.8	43.3	23.9	13.4	2.1	0	2.3	4.78	47.71	7.35	7.32	6.85	16.96	7.86
20.1	19.8	18.3	28.2	38.8	42.3	50	64.1	59.8	71.3	78.2	103.2	65.9	67.5	81.4	74.9	52.9	51.3	30.1	31.1	37.95	56.45	103.75	72.28	84.69	79.31	94.43	135.9
0	0	0	0	0	0	0	0	0	0	0	0	24.8	42.8	32.1	31.5	34.7	21.2	5.9	1.09	0	43.05	0.89	3.18	1.65	2.16	4.4	7.84
0	0	0	0	0	0	0	0	0.5	1.5	1.9	3.6	6.6	9.6	11.7	11.6	11.4	0	0	0	0	0	0	0	17.37	21.7	19.74	16.92
2.9	2.3	4.7	5	2.7	2.6	18.4	16	10.4	11.6	12.5	19.3	21	10.3	6.2	5.6	3.1	3.6	2.7	4.15	8.39	9.96	6.41	4.56	4.94	4.6	4.82	1.11
2.9	2.3	4.7	5	2.7	2.6	18.4	16	10.9	13.1	14.4	22.9	52.4	62.7	50	48.7	49.2	24.8	8.6	5.24	8.39	53.02	7.3	7.74	23.96	28.46	28.96	25.86
23	22.1	23	33.2	41.5	44.9	68.4	80.1	70.7	84.4	92.6	126.1	118.3	130.2	131.4	123.6	102.1	76.1	38.7	36.34	46.34	109.47	111.05	80.02	108.64	107.77	123.39	161.76
106.9	115.1	123.5	135.5	145.1	147.5	176.7	197.9	190.7	216	234	278.3	276.6	294.9	299	293.6	289.3	276.2	270.7	293.88	334.53	432.72	476.2	498.25	585.3	648.84	729.73	835.14

Scope 1 - Direct Emissions	3,874.06
Scope 2 - Indirect emissions from purchased energy	1,652
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions	5,526
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Percentage of female employees	54
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

Stock Exchange	Faes Farma Ticker
BME	FAE.MC
DÜSSELDORF	FFEA.DU
EURONEXT	FAE.MC
FRANKFURT	FFEA.F
LONDON	0K9H.L
MADRID	FAE.MC
MUNICH	FFEA.MU

1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e	2027e
94	103	110	121	134	149	152	173	165	168	192	203	196	199	211	195	176	180	191	204	228	274	324	357	380	398	438	451	500	513	523	521
-	9.57	6.80	10.00	10.74	11.19	2.01	13.82	-4.62	1.82	14.29	5.73	-3.45	1.53	6.03	-7.58	-9.74	2.27	6.11	6.81	11.76	20.18	18.25	10.19	6.44	4.74	10.05	2.97	10.86	2.60	1.95	-0.38
69.15	68.93	67.27	66.12	64.93	65.10	65.13	64.16	66.06	67.26	66.67	66.50	60.71	60.80	60.19	62.05	64.20	63.33	65.97	65.20	66.23	64.96	62.96	63.59	62.89	63.32	64.38	65.85	59.40	57.89	56.79	57.01
65	71	74	80	87	97	99	111	109	113	128	135	119	121	127	121	113	114	126	133	151	178	204	227	239	252	282	297	0	0	0	0
14	20	25	26	20	14	15	19	20	23	22	21	19	21	20	14	19	22	25	30	36	41	51	63	72	82	89	91	93	96	96	91
-	42.86	25.00	4.00	-23.08	-30.00	7.14	26.67	5.26	15.00	-4.35	-4.55	-9.52	10.53	-4.76	-30.00	35.71	15.79	13.64	20.00	20.00	13.89	24.39	23.53	14.29	13.89	8.54	2.25	2.20	3.23	-	-5.21
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
33.2	36.5	194.1	213.8	213.8	213.8	235.2	231	232.2	232.2	234.6	234.6	263.9	285.8	285.6	282.8	276.6	278.1	272.5	293.53	298.94	295.71	306.07	306.08	316.33	329.67	316.63	310.73	0	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Faes Farma Ticker	Faes Farma FIGI
FAE:SM	BBG000BH1392
FAE:SQ	BBG000BH15J6
FAEE:TQ	BBG000C2C891
FFEA:GR	BBG000C2SS72
FFEA:GF	BBG000C2STZ9
FFEA:GD	BBG000C2SV48
FFEA:GS	BBG000C2SVV8
FFEA:GM	BBG000C2SWX4
FFEA:GB	BBG000C2SX44
FAE:EO	BBG000CQK9V2
FAE:XH	BBG000CQKCR0
FAE:XC	BBG000CQKD34
FAE:XF	BBG000CQKDY0
FAE:XE	BBG000CQKG91
FAE:XJ	BBG000CQKGG3
FAE:XL	BBG000CQLJ85
FAE:XG	BBG000CQLJN8
FAE:XO	BBG000CQLL26
FAE:XS	BBG000CQLNS4
FAE:XA	BBG000CQLP63
FAE:E1	BBG000CQLPF3
FAE:XT	BBG000CQLQ16
FAE:XW	BBG000CQLQ61
FAE:EU	BBG000CQLRK3
FAEGBX:EU	BBG000CXXL37
FAEGBX:EO	BBG000CXXLL7
FAEGBX:XH	BBG000CXXMK6
FAEGBX:XC	BBG000CXXNH8
FAEGBX:XE	BBG000CXXQK7
FAEGBX:XJ	BBG000CXXQR0
FAEGBX:XG	BBG000CXYSQ6
FAEGBX:XO	BBG000CXYTD8
FAEGBX:XS	BBG000CXYW78
FAEGBX:XA	BBG000CXYWJ5
FAEGBX:E1	BBG000CXYWN0
FAEGBX:XT	BBG000CXYX85
FAEGBX:XW	BBG000CXYXZ5
FAEGBP:EO	BBG000D42780
FAEGBP:XH	BBG000D42904
FAEGBP:XC	BBG000D429Y7
FAEGBP:XE	BBG000D42CK5
FAEGBP:XJ	BBG000D42CP0
FAEGBP:XG	BBG000D42D87
FAEGBP:XO	BBG000D42F37
FAEGBP:XS	BBG000D42H15
FAEGBP:XA	BBG000D42HB4
FAEGBP:E1	BBG000D42HR7
FAEGBP:XT	BBG000D42J39
FAEGBP:XW	BBG000D42J84
FAEE:S1	BBG001MBXDP6
FAEE:EB	BBG004LMGVH5
FAEE:IX	BBG004LNK7D5
FAE:XV	BBG00591JNW0
FAEGBX:XV	BBG00591MBG0
FAEGBP:XV	BBG00591PXC3
FAEE:B3	BBG006T6LTV0
FAEE:L3	BBG006T9XL20
FAEE:PO	BBG008GZMW02
FAEE:BQ	BBG009L209Q4
FFEA:QT	BBG00DB571Q9
FAE:XM	BBG00J9VNM15
FAE:XX	BBG00JN7G9P3
FAEGBX:XX	BBG00JN7JZM5
FAEGBP:XX	BBG00JN7MKB6
0K9H:LO	BBG00JVX9GQ8
FAEE:QX	BBG00M0XD6J0
FAEEUR:T2	BBG00N0091M2
FAEE:QE	BBG00NL2S1P1
FAEE:T1	BBG00NLK4GN6
FAEE:I2	BBG00NQC4L94
FAEEUR:WT	BBG00NR93FX7
FFEA:TH	BBG00QGQGD83
FAEE:L1	BBG00Y910592
FAEE:S4	BBG00YJ80XS4
FFEA:GZ	BBG0146SF318
FFEA:LA	BBG018H8DXW3
FFEA:LU	BBG018J220F7

Access the world's leading financial data and tools

Price

Price

TickerFAE.MC

ISINES0134950F36

WKNA0MKAC

Faes Farma stock price

Price

Overview

Intraday Feature

Total Return and Relative Price Change

Interpretation and Investment

Faes Farma Stock Price History

Faes Farma Revenue, EBIT, Net Income ES0134950F36 · A0MKAC

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Yearly Analysis and Comparisons

Utilizing Expectations for Investment

Investment Insights

Faes Farma Revenue, EBIT and net profit per share

Faes Farma Income Statement, Balance Sheet, Cash Flow Statement

Keystats

Revenue and Growth

Gross Margin

EBIT and EBIT Margin

Income and Growth

Shares Outstanding

Interpreting Year to Year Comparison

Expectations and Predictions

Balance Sheet

Understanding the Balance Sheet

Assets

Liabilities

Equity

Year-to-Year Analysis

Interpreting the Data

Faes Farma stock margins ES0134950F36 · A0MKAC

Margin

Understanding Gross Margin

EBIT Margin Analysis

Revenue Margin Insights

Interpreting Expectations

Comparative Analysis

Faes Farma Margin History

Faes Farma Stock Sales Revenue, EBIT, Earnings per Share ES0134950F36 · A0MKAC

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

Faes Farma Revenue, EBIT and net profit per share

Faes Farma business model

Faes Farma SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

The World’s Best Investors Are On Eulerpool

Faes Farma Eulerpool Fair Value

Fair Value

Understanding Fair Value

Income-Based Fair Value

Revenue-Based Fair Value

Dividend-Based Fair Value

Expectations and Forecasts

Comparative Analysis

Faes Farma historical P/E ratio, EBIT multiple, and P/S ratio

The World’s Best Investors Are On Eulerpool

Faes Farma shares outstanding ES0134950F36 · A0MKAC

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

Faes Farma stock splits

Faes Farma dividend history and estimates ES0134950F36 · A0MKAC

Dividend

Dividend Overview

Interpretation and Use

Investment Strategy

Ticker
FAE.MC

ISIN
ES0134950F36

WKN
A0MKAC